Russell Investments Group
DRUG

Russell Investments Group’s Bright Minds Biosciences DRUG Stock Holding History

Russell Investments Group’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.4K Sell
882
-52
-6% -$4.19K ﹤0.01% 3225
2025
Q4 		$72.9K Sell
934
-17
-2% -$1.14K ﹤0.01% 3163
2025
Q3 		$57.7K Buy
+951
New +$36.9K ﹤0.01% 3227

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Russell Investments Group's DRUG Position: Q1 2026 in Review

Russell Investments Group reduced its Bright Minds Biosciences (DRUG) stake by 5.6% in Q1 2026, selling an estimated $4.19K and leaving 882 shares worth $64.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3225.

Russell Investments Group first reported a position in DRUG in Q3 2025 and has held it in 3 quarters since. The position peaked at $72.9K in Q4 2025. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Russell Investments Group held 882 shares of Bright Minds Biosciences worth $64.4K as of Q1 2026.
  • Russell Investments Group sold 52 Bright Minds Biosciences shares in Q1 2026, an estimated $4.19K.
  • Bright Minds Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3225 holding.
  • Russell Investments Group first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Russell Investments Group's Bright Minds Biosciences position peaked at $72.9K in Q4 2025.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.